We are monitoring the impact of COVID-19 on APAC Contraceptives Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1157
Share on
Share on

Asia Pacific Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (India, China, Japan, Australia, New Zealand, ASEAN Countries and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 1157
Pages: 136

As per our report, the size of the Asia Pacific Contraceptives Market was worth USD 5.37 billion in 2020 and estimated to reach USD 7.52 billion by the end of 2025, with a growing potential of 6.95%.

The main factors leading to the growth of the contraceptive and device market in the Asia-Pacific region include the need to avoid unnecessary pregnancy and its complications. The need to prevent unintended pregnancy, especially among teenage girls, is one of the main driving forces of the market. It has also been observed that more than half of women believe that the use of non-contraceptive pills is good for health, such as treating menstrual periods, menstrual pain, and acne. It is also one of the factors contributing to market growth. 

The increasing incidence of sexually transmitted diseases and the rapid increase in the population are lucratively elevating the demand of the APAC Contraceptives Market. Government initiatives are also one of the factors fueling the need for the market. 

The related risks associated, social, and cultural impacts of contraceptives and infertility caused by the use of contraceptives are significant obstacles to APAC Contraceptives Market growth.

The spread of sexually transmitted diseases and increasing population control leads the demand in the market. The Asia-Pacific contraceptive market is estimated to grow at a profitable rate during the forecast period, and the implementation of measures aimed at reducing unintended pregnancies related to health care costs and the subsequent increase in user awareness is creating the opportunities in the market. 

The availability of alternative contraceptive methods is the main challenge in the APAC Contraceptives Market.

This research report has been segmented & sub-segmented into the following categories:

  • By Drug Type: Contraceptive Pills, Topical Contraceptives, Contraceptive Injectable & Others (Contraceptive Gels, Jellies, and Creams)
  • By Medical Devices: Male Contraceptive Devices (Condoms), Female Contraceptive Devices (Female Condoms, Intrauterine Devices (Hormonal IUD’s, Copper IUD’s)), Contraceptive Sponges, Contraceptive Diaphragms, Subdermal Contraceptive Implants, Contraceptive Patches, Non-Surgical Permanent Contraceptive Devices
  • By End User: Hospitals, Home Care, Clinics & Ambulatory Surgical Centres
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regionally, Asia Pacific was profoundly influencing the industry in terms of demographics and lack of awareness within the large population. Favorable government initiatives about sex education of individuals is one of the major factor expected to boost the contraceptives market growth over the forecast period.

Notable companies dominating the APAC contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug type                              

                                5.1.1 Contraceptive pills               

                                5.1.2 Topical contraceptives       

                                5.1.3 Contraceptive injectable   

                                5.1.4 Others (contraceptive gels, jellies and creams)        

                5.2 By Medical Devices                 

                                5.2.1 Male contraceptive devices             

                                5.2.2 Female contraceptive devices        

                                                5.2.2.1 Female condoms

                                                5.2.2.2 Intrauterine devices

                                                5.2.2.3 Contraceptive sponges

                                                5.2.2.4 Contraceptive diaphragms

                                                5.2.2.5 Contraceptive patches

                                                5.2.2.6 Subdermal contraceptive implants

                                                5.2.2.7 Non-surgical permanent contraceptive devices

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer HealthCare AG                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Teva Pharmaceutical Industries Limited                         

                8.3 Medisafe Distribution Inc                     

                8.4 Pace Pharmaceuticals Inc                     

                8.5 Medicines360                            

                8.6 Church & Dwight, Co., Inc.                   

                8.7 Actavis, Inc                 

                8.8 CooperSurgical                         

                8.9 Merck & Co., Inc                       

                8.10 Reckitt Benckiser plc                            

                8.11 Mayer Laboratories, Inc                      

                8.12 Pfizer, Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia-Pacific Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  2. Asia-Pacific Contraceptive pills Market By Region, From 2020 to 2025 (USD Billion)
  3. Asia-Pacific Topical contraceptives Market By Region, From 2020 to 2025 (USD Billion)
  4. Asia-Pacific Contraceptive injectable Market By Region, From 2020 to 2025 (USD Billion)
  5. Asia-Pacific Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  6. Asia-Pacific Male Contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  7. Asia-Pacific Female Contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  8. Asia-Pacific Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  9. Asia-Pacific Hospitals Market By Region, From 2020 to 2025 (USD Billion)
  10. Asia-Pacific Home care Market By Region, From 2020 to 2025 (USD Billion)
  11. Asia-Pacific Clinics Market By Region, From 2020 to 2025 (USD Billion)
  12. Asia-Pacific Ambulatory Surgical Centres Market By Region, From 2020 to 2025 (USD Billion)
  13. Japan Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  14. Japan Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  15. Japan Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  16. China Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  17. China Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  18. China Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  19. India Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  20. India Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  21. India Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  22. Asia-Pacific Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  23. Asia-Pacific female condoms Market By Region, From 2020 to 2025 (USD Billion)
  24. Asia-Pacific intrauterine devices Market By Region, From 2020 to 2025 (USD Billion)
  25. Asia-Pacific contraceptive sponges Market By Region, From 2020 to 2025 (USD Billion)
  26. Asia-Pacific contraceptive diaphragms Market By Region, From 2020 to 2025 (USD Billion)
  27. Asia-Pacific contraceptive patches Market By Region, From 2020 to 2025 (USD Billion)
  28. Asia-Pacific subdermal contraceptive implants Market By Region, From 2020 to 2025 (USD Billion)
  29. Asia-Pacific non-surgical permanent contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  30. Japan Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  31. China Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  32. India Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  33. Asia-Pacific Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  34. Asia-Pacific female condoms Market By Region, From 2020 to 2025 (USD Billion)
  35. Asia-Pacific intrauterine devices Market By Region, From 2020 to 2025 (USD Billion)
  36. Asia-Pacific contraceptive sponges Market By Region, From 2020 to 2025 (USD Billion)
  37. Asia-Pacific contraceptive diaphragms Market By Region, From 2020 to 2025 (USD Billion)
  38. Asia-Pacific contraceptive patches Market By Region, From 2020 to 2025 (USD Billion)
  39. Asia-Pacific subdermal contraceptive implants Market By Region, From 2020 to 2025 (USD Billion)
  40. Asia-Pacific non-surgical permanent contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  41. Japan Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  42. China Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  43. India Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  44. Asia-Pacific Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  45. Asia-Pacific Hormonal IUD's Market By Region, From 2020 to 2025 (USD Billion)
  46. Japan Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  47. China Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  48. India Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample